{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T04:04:22Z","timestamp":1782446662196,"version":"3.54.5"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81891012"],"award-info":[{"award-number":["81891012"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["2021JDRC0041"],"award-info":[{"award-number":["2021JDRC0041"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine","award":["ZYYCXTD-D-202209"],"award-info":[{"award-number":["ZYYCXTD-D-202209"]}]},{"name":"Sichuan TCM Science and Technology Industry Innovation Team","award":["2022C001"],"award-info":[{"award-number":["2022C001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s10753-023-01826-1","type":"journal-article","created":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T06:02:06Z","timestamp":1684821726000},"page":"1543-1560","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Phillygenin Ameliorates Carbon Tetrachloride-Induced Liver Fibrosis: Suppression of Inflammation and Wnt\/\u03b2-Catenin Signaling Pathway"],"prefix":"10.1007","volume":"46","author":[{"given":"Cheng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyan","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,23]]},"reference":[{"issue":"4","key":"1826_CR1","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.jhep.2015.03.039","volume":"63","author":"F Tacke","year":"2015","unstructured":"Tacke, F., and C. Trautwein. 2015. Mechanisms of liver fibrosis resolution. Journal of hepatology 63 (4): 1038\u20131039.","journal-title":"Journal of hepatology"},{"issue":"3","key":"1826_CR2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","volume":"18","author":"T Kisseleva","year":"2021","unstructured":"Kisseleva, T., and D. Brenner. 2021. Molecular and cellular mechanisms of liver fibrosis and its regression. Nature reviews Gastroenterology & hepatology 18 (3): 151\u2013166.","journal-title":"Nature reviews Gastroenterology & hepatology"},{"issue":"1","key":"1826_CR3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.5152\/tjg.2018.17330","volume":"29","author":"M Ayd\u0131n","year":"2018","unstructured":"Ayd\u0131n, M., and K. Ak\u00e7al\u0131. 2018. Liver fibrosis. The Turkish journal of gastroenterology\u202f: The official journal of Turkish Society of Gastroenterology 29 (1): 14\u201321.","journal-title":"The Turkish journal of gastroenterology : The official journal of Turkish Society of Gastroenterology"},{"key":"1826_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","volume":"121","author":"T Higashi","year":"2017","unstructured":"Higashi, T., S.L. Friedman, and Y. Hoshida. 2017. Hepatic stellate cells as key target in liver fibrosis. Advanced Drug Delivery Reviews 121: 27\u201342.","journal-title":"Advanced Drug Delivery Reviews"},{"key":"1826_CR5","doi-asserted-by":"crossref","unstructured":"Sun, M., and T. Kisseleva. 2015. Reversibility of liver fibrosis.\u00a0Clinics and Research in Hepatology and Gastroenterology\u00a039 Suppl 1(0 1):S60\u201363.","DOI":"10.1016\/j.clinre.2015.06.015"},{"key":"1826_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","volume":"65","author":"M Parola","year":"2019","unstructured":"Parola, M., and M. Pinzani. 2019. Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues. Molecular Aspects of Medicine 65: 37\u201355.","journal-title":"Molecular Aspects of Medicine"},{"key":"1826_CR7","doi-asserted-by":"crossref","unstructured":"Llovet, J.M., J. Zucman-Rossi, E. Pikarsky, B. Sangro, M. Schwartz, M. Sherman, G. Gores. 2016. Hepatocellular carcinoma. Nat Rev Dis Primers 2: 16018","DOI":"10.1038\/nrdp.2016.18"},{"issue":"1","key":"1826_CR8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1172\/JCI88881","volume":"127","author":"Y Koyama","year":"2017","unstructured":"Koyama, Y., and D.A. Brenner. 2017. Liver inflammation and fibrosis. The Journal of Clinical Investigation 127 (1): 55\u201364.","journal-title":"The Journal of Clinical Investigation"},{"issue":"1","key":"1826_CR9","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1080\/08923973.2018.1547742","volume":"41","author":"B Du","year":"2019","unstructured":"Du, B., L. Zhang, Y. Sun, G. Zhang, J. Yao, M. Jiang, L. Pan, and C. Sun. 2019. Phillygenin exhibits anti-inflammatory activity through modulating multiple cellular behaviors of mouse lymphocytes. Immunopharmacology and Immunotoxicology 41 (1): 76\u201385.","journal-title":"Immunopharmacology and Immunotoxicology"},{"key":"1826_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2019.112361","volume":"248","author":"N Hu","year":"2020","unstructured":"Hu, N., C. Wang, X. Dai, M. Zhou, L. Gong, L. Yu, C. Peng, and Y. Li. 2020. Phillygenin inhibits LPS-induced activation and inflammation of LX2 cells by TLR4\/MyD88\/NF-\u03baB signaling pathway. Journal of Ethnopharmacology 248: 112361.","journal-title":"Journal of Ethnopharmacology"},{"issue":"2","key":"1826_CR11","first-page":"713","volume":"42","author":"M Katoh","year":"2018","unstructured":"Katoh, M. 2018. Multi-layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT\/\u03b2-catenin signaling activation (Review). International Journal of Molecular Medicine 42 (2): 713\u2013725.","journal-title":"International Journal of Molecular Medicine"},{"issue":"3","key":"1826_CR12","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/s41581-020-00343-w","volume":"17","author":"SJ Schunk","year":"2021","unstructured":"Schunk, S.J., J. Floege, D. Fliser, and T. Speer. 2021. WNT-\u03b2-catenin signalling - a versatile player in kidney injury and repair. Nature Reviews. Nephrology 17 (3): 172\u2013184.","journal-title":"Nature Reviews. Nephrology"},{"issue":"4","key":"1826_CR13","doi-asserted-by":"publisher","first-page":"337","DOI":"10.33549\/physiolres.932289","volume":"61","author":"Y Guo","year":"2012","unstructured":"Guo, Y., L. Xiao, L. Sun, and F. Liu. 2012. Wnt\/beta-catenin signaling: A promising new target for fibrosis diseases. Physiological Research 61 (4): 337\u2013346.","journal-title":"Physiological Research"},{"issue":"3","key":"1826_CR14","doi-asserted-by":"publisher","first-page":"282","DOI":"10.5009\/gnl.2014.8.3.282","volume":"8","author":"W Li","year":"2014","unstructured":"Li, W., C. Zhu, Y. Li, Q. Wu, and R. Gao. 2014. Mest attenuates CCl4-induced liver fibrosis in rats by inhibiting the Wnt\/\u03b2-catenin signaling pathway. Gut Liver 8 (3): 282\u2013291.","journal-title":"Gut Liver"},{"issue":"1","key":"1826_CR15","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13287-019-1204-2","volume":"10","author":"X Rong","year":"2019","unstructured":"Rong, X., J. Liu, X. Yao, T. Jiang, Y. Wang, and F. Xie. 2019. Human bone marrow mesenchymal stem cells-derived exosomes alleviate liver fibrosis through the Wnt\/\u03b2-catenin pathway. Stem Cell Research & Therapy 10 (1): 98.","journal-title":"Stem Cell Research & Therapy"},{"issue":"1","key":"1826_CR16","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s13287-022-02906-z","volume":"13","author":"QW Liu","year":"2022","unstructured":"Liu, Q.W., Y.M. Ying, J.X. Zhou, W.J. Zhang, Z.X. Liu, B.B. Jia, H.C. Gu, C.Y. Zhao, X.H. Guan, K.Y. Deng, et al. 2022. Human amniotic mesenchymal stem cells-derived IGFBP-3, DKK-3, and DKK-1 attenuate liver fibrosis through inhibiting hepatic stellate cell activation by blocking Wnt\/\u03b2-catenin signaling pathway in mice. Stem Cell Research & Therapy 13 (1): 224.","journal-title":"Stem Cell Research & Therapy"},{"issue":"12","key":"1826_CR17","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1016\/j.biochi.2013.09.003","volume":"95","author":"C Miao","year":"2013","unstructured":"Miao, C., Y. Yang, X. He, C. Huang, Y. Huang, L. Zhang, X. Lv, Y. Jin, and J. Li. 2013. Wnt signaling in liver fibrosis: Progress, challenges and potential directions. Biochimie 95 (12): 2326\u20132335.","journal-title":"Biochimie"},{"key":"1826_CR18","doi-asserted-by":"crossref","unstructured":"Nishikawa, K., Y. Osawa, K. Kimura. 2018. Wnt\/\u03b2-catenin signaling as a potential target for the treatment of liver cirrhosis using antifibrotic drugs. International Journal of Molecular Sciences 19(10)","DOI":"10.3390\/ijms19103103"},{"key":"1826_CR19","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.gene.2018.06.053","volume":"674","author":"J Wang","year":"2018","unstructured":"Wang, J., L. Li, L. Li, Q. Yan, J. Li, and T. Xu. 2018. Emerging role and therapeutic implication of Wnt signaling pathways in liver fibrosis. Gene 674: 57\u201369.","journal-title":"Gene"},{"issue":"7","key":"1826_CR20","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/jhbp.245","volume":"22","author":"E Seki","year":"2015","unstructured":"Seki, E., and D. Brenner. 2015. Recent advancement of molecular mechanisms of liver fibrosis. Journal of hepato-biliary-pancreatic sciences 22 (7): 512\u2013518.","journal-title":"Journal of hepato-biliary-pancreatic sciences"},{"key":"1826_CR21","doi-asserted-by":"crossref","unstructured":"Sun, M., T. Kisseleva. 2015. Reversibility of liver fibrosis. Clinics and Research in Hepatology and Gastroenterology\u00a0S60\u201363","DOI":"10.1016\/j.clinre.2015.06.015"},{"issue":"2","key":"1826_CR22","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3904\/kjim.2016.268","volume":"32","author":"Y Jung","year":"2017","unstructured":"Jung, Y., and H. Yim. 2017. Reversal of liver cirrhosis: Current evidence and expectations. The Korean journal of internal medicine 32 (2): 213\u2013228.","journal-title":"The Korean journal of internal medicine"},{"issue":"2","key":"1826_CR23","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1177\/1535370219898141","volume":"245","author":"D Dhar","year":"2020","unstructured":"Dhar, D., J. Baglieri, T. Kisseleva, and D. Brenner. 2020. Mechanisms of liver fibrosis and its role in liver cancer. Experimental biology and medicine (Maywood, NJ) 245 (2): 96\u2013108.","journal-title":"Experimental biology and medicine (Maywood, NJ)"},{"issue":"1","key":"1826_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/s-0036-1597816","volume":"37","author":"L Campana","year":"2017","unstructured":"Campana, L., and J. Iredale. 2017. Regression of liver fibrosis. Seminars in liver disease 37 (1): 1\u201310.","journal-title":"Seminars in liver disease"},{"issue":"5","key":"1826_CR25","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s00204-015-1543-4","volume":"90","author":"S Yanguas","year":"2016","unstructured":"Yanguas, S., B. Cogliati, J. Willebrords, M. Maes, I. Colle, B. van den Bossche, C. de Oliveira, W. Andraus, V. Alves, I. Leclercq, et al. 2016. Experimental models of liver fibrosis. Archives of toxicology 90 (5): 1025\u20131048.","journal-title":"Archives of toxicology"},{"key":"1826_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.666138","volume":"12","author":"Y Bao","year":"2021","unstructured":"Bao, Y., L. Wang, H. Pan, T. Zhang, Y. Chen, S. Xu, X. Mao, and S. Li. 2021. Animal and organoid models of liver fibrosis. Frontiers in physiology 12: 666138.","journal-title":"Frontiers in physiology"},{"key":"1826_CR27","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1177\/0023677215571192","volume":"49","author":"D Scholten","year":"2015","unstructured":"Scholten, D., J. Trebicka, C. Liedtke, and R. Weiskirchen. 2015. The carbon tetrachloride model in mice. Laboratory animals 49: 4\u201311.","journal-title":"Laboratory animals"},{"key":"1826_CR28","doi-asserted-by":"crossref","unstructured":"Chang, M.J., T.M. Hung, B.S. Min, J.C. Kim, M.H. Woo, J.S. Choi, H.K. Lee, K. Bae. 2008. Lignans from the fruits of Forsythia suspensa (Thunb.) Vahl protect high-density lipoprotein during oxidative stress.\u00a0Bioscience, Biotechnology and Biochemistry\u00a072(10): 2750\u20132755","DOI":"10.1271\/bbb.80392"},{"key":"1826_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.863624","volume":"13","author":"RJ Li","year":"2022","unstructured":"Li, R.J., C. Qin, G.R. Huang, L.J. Liao, X.Q. Mo, and Y.Q. Huang. 2022. Phillygenin inhibits helicobacter pylori by preventing biofilm formation and inducing ATP Leakage. Frontiers in Microbiology 13: 863624.","journal-title":"Frontiers in Microbiology"},{"key":"1826_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108764","volume":"108","author":"H Feng","year":"2022","unstructured":"Feng, H., J. Zhang, K. Zhang, X. Wang, K. Zhang, Z. Guo, S. Han, L. Wang, Z. Qiu, G. Wang, et al. 2022. Phillygenin activates PKR\/eIF2\u03b1 pathway and induces stress granule to exert anti-avian infectious bronchitis virus. International Immunopharmacology 108: 108764.","journal-title":"International Immunopharmacology"},{"key":"1826_CR31","doi-asserted-by":"publisher","first-page":"7964318","DOI":"10.1155\/2018\/7964318","volume":"2018","author":"W Song","year":"2018","unstructured":"Song, W., J. Wu, L. Yu, and Z. Peng. 2018. Evaluation of the pharmacokinetics and hepatoprotective effects of phillygenin in mouse. BioMed Research International 2018: 7964318.","journal-title":"BioMed Research International"},{"key":"1826_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115478","volume":"296","author":"C Wang","year":"2022","unstructured":"Wang, C., C. Ma, K. Fu, Y. Liu, L. Gong, C. Peng, and Y. Li. 2022. Hepatoprotective effect of phillygenin on carbon tetrachloride-induced liver fibrosis and its effects on short chain fatty acid and bile acid metabolism. Journal of Ethnopharmacology 296: 115478.","journal-title":"Journal of Ethnopharmacology"},{"key":"1826_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114264","volume":"159","author":"C Ma","year":"2023","unstructured":"Ma, C., C. Wang, Y. Zhang, Y. Li, K. Fu, L. Gong, H. Zhou, and Y. Li. 2023. Phillygenin inhibited M1 macrophage polarization and reduced hepatic stellate cell activation by inhibiting macrophage exosomal miR-125b-5p. Biomedicine & Pharmacotherapy 159: 114264.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"1","key":"1826_CR34","doi-asserted-by":"publisher","first-page":"5872","DOI":"10.1038\/s41598-017-06318-5","volume":"7","author":"X Li","year":"2017","unstructured":"Li, X., L. Wang, and C. Chen. 2017. Effects of exogenous thymosin \u03b24 on carbon tetrachloride-induced liver injury and fibrosis. Scientific reports 7 (1): 5872.","journal-title":"Scientific reports"},{"issue":"3","key":"1826_CR35","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/MOG.0b013e3283279668","volume":"25","author":"J Jiao","year":"2009","unstructured":"Jiao, J., S. Friedman, and C. Aloman. 2009. Hepatic fibrosis. Current opinion in gastroenterology 25 (3): 223\u2013229.","journal-title":"Current opinion in gastroenterology"},{"issue":"5","key":"1826_CR36","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nri.2017.11","volume":"17","author":"O Krenkel","year":"2017","unstructured":"Krenkel, O., and F. Tacke. 2017. Liver macrophages in tissue homeostasis and disease. Nature reviews Immunology 17 (5): 306\u2013321.","journal-title":"Nature reviews Immunology"},{"key":"1826_CR37","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3389\/fphar.2018.00072","volume":"9","author":"X Li","year":"2018","unstructured":"Li, X., Q. Jin, Q. Yao, B. Xu, L. Li, S. Zhang, and C. Tu. 2018. The flavonoid quercetin ameliorates liver inflammation and fibrosis by regulating hepatic macrophages activation and polarization in mice. Frontiers in pharmacology 9: 72.","journal-title":"Frontiers in pharmacology"},{"issue":"1","key":"1826_CR38","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.apsb.2020.07.004","volume":"11","author":"Z Yan","year":"2021","unstructured":"Yan, Z., D. Wang, C. An, H. Xu, Q. Zhao, Y. Shi, N. Song, B. Deng, X. Guo, J. Rao, et al. 2021. viaThe antimicrobial peptide YD attenuates inflammation miR-155 targeting CASP12 during liver fibrosis. Acta pharmaceutica Sinica B 11 (1): 100\u2013111.","journal-title":"Acta pharmaceutica Sinica B"},{"issue":"6","key":"1826_CR39","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","volume":"169","author":"R Nusse","year":"2017","unstructured":"Nusse, R., and H. Clevers. 2017. Wnt\/\u03b2-catenin signaling, disease, and emerging therapeutic modalities. Cell 169 (6): 985\u2013999.","journal-title":"Cell"},{"issue":"1","key":"1826_CR40","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/s41598-017-00282-w","volume":"7","author":"Y Tokunaga","year":"2017","unstructured":"Tokunaga, Y., Y. Osawa, T. Ohtsuki, Y. Hayashi, K. Yamaji, D. Yamane, M. Hara, K. Munekata, K. Tsukiyama-Kohara, T. Hishima, et al. 2017. Selective inhibitor of Wnt\/\u03b2-catenin\/CBP signaling ameliorates hepatitis C virus-induced liver fibrosis in mouse model. Science and Reports 7 (1): 325.","journal-title":"Science and Reports"},{"issue":"2","key":"1826_CR41","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1159\/000430128","volume":"36","author":"MQ Jiang","year":"2015","unstructured":"Jiang, M.Q., L. Wang, A.L. Cao, J. Zhao, X. Chen, Y.M. Wang, H. Wang, and W. Peng. 2015. HuangQi decoction improves renal tubulointerstitial fibrosis in mice by inhibiting the up-regulation of Wnt\/\u03b2-catenin signaling pathway. Cellular Physiology and Biochemistry 36 (2): 655\u2013669.","journal-title":"Cellular Physiology and Biochemistry"},{"issue":"1","key":"1826_CR42","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.yexcr.2017.07.025","volume":"359","author":"S Guan","year":"2017","unstructured":"Guan, S., and J. Zhou. 2017. Frizzled-7 mediates TGF-\u03b2-induced pulmonary fibrosis by transmitting non-canonical Wnt signaling. Experimental Cell Research 359 (1): 226\u2013234.","journal-title":"Experimental Cell Research"},{"key":"1826_CR43","doi-asserted-by":"crossref","unstructured":"Nishikawa, K., Y. Osawa, K. Kimura. 2018. Wnt\/\u03b2-catenin signaling as a potential target for the treatment of liver cirrhosis using antifibrotic drugs.\u00a0International Journal of Molecular Sciences\u00a019(10)","DOI":"10.3390\/ijms19103103"},{"issue":"3","key":"1826_CR44","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jhep.2006.03.016","volume":"45","author":"F Jiang","year":"2006","unstructured":"Jiang, F., C.J. Parsons, and B. Stefanovic. 2006. Gene expression profile of quiescent and activated rat hepatic stellate cells implicates Wnt signaling pathway in activation. Journal of Hepatology 45 (3): 401\u2013409.","journal-title":"Journal of Hepatology"},{"issue":"1","key":"1826_CR45","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ydbio.2013.08.007","volume":"383","author":"A Koehler","year":"2013","unstructured":"Koehler, A., J. Schlupf, M. Schneider, B. Kraft, C. Winter, and J. Kashef. 2013. Loss of Xenopus cadherin-11 leads to increased Wnt\/\u03b2-catenin signaling and up-regulation of target genes c-myc and cyclin D1 in neural crest. Developmental Biology 383 (1): 132\u2013145.","journal-title":"Developmental Biology"},{"issue":"36","key":"1826_CR46","doi-asserted-by":"publisher","first-page":"4178","DOI":"10.3748\/wjg.v24.i36.4178","volume":"24","author":"GR Huang","year":"2018","unstructured":"Huang, G.R., S.J. Wei, Y.Q. Huang, W. Xing, L.Y. Wang, and L.L. Liang. 2018. Mechanism of combined use of vitamin D and puerarin in anti-hepatic fibrosis by regulating the Wnt\/\u03b2-catenin signalling pathway. World Journal of Gastroenterology 24 (36): 4178\u20134185.","journal-title":"World Journal of Gastroenterology"},{"key":"1826_CR47","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.intimp.2018.08.005","volume":"63","author":"C Zhang","year":"2018","unstructured":"Zhang, C., X.Q. Liu, H.N. Sun, X.M. Meng, Y.W. Bao, H.P. Zhang, F.M. Pan, and C. Zhang. 2018. Octreotide attenuates hepatic fibrosis and hepatic stellate cells proliferation and activation by inhibiting Wnt\/\u03b2-catenin signaling pathway, c-Myc and cyclin D1. International Immunopharmacology 63: 183\u2013190.","journal-title":"International Immunopharmacology"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-023-01826-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-023-01826-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-023-01826-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T07:14:59Z","timestamp":1689837299000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-023-01826-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,23]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["1826"],"URL":"https:\/\/doi.org\/10.1007\/s10753-023-01826-1","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,23]]},"assertion":[{"value":"28 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The whole experimental scheme was approved by the Animal Experiment Ethics Committee of Chengdu University of traditional Chinese medicine and carried out under its supervision (Permit number: SYXK 2020\u2013124).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"All authors have read the manuscript and authorized its publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}